215. Яхно Н. Н., Коберская Н. Н., Дамулин И. В. и др. Организация помощи пациентам с нарушениями памяти и другими когнитивными расстройствам // Неврол. журн. – 2006. – № 1. – С. 75–79.
216. Яхно Н. Н., Нодель М. Р., Федорова Н. В. и др. Эффективность и переносимость препарата сталево при болезни Паркинсона // Неврол. журн. – 2007. – № 6. – С. 48–52.
217. Abrahams S., Leigh P N., Harvey A et al. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis // Neuropsychologia. – 2000. – V. 38. – № 5. – P. 734–747.
218. Abreu-Villaca Y., Seidler F.J., Tate C.A. et al. Prenatal nicotine exposure alters the response to nicotine administration in adolescence // Neuropsychopharmacology. – 2004. – V. 29. – № 5. – P. 879–890.
219. Adams R. D., Victor M., Ropper A. H. Principles of neurology. – NY.: McGraw-Hill, 2001. – 1692 p.
220. Aguzzi A. Prion diseases of humans and farm animals // J. of Neurochem. – 2006. – V. 97. – № 6. – P. 1726–1739.
221. Amaducci L., Grassi E., Boller F. Maurice Ravel and right-hemisphere musical creativity // Eur J Neurol. – 2002. – № 1. – P. 75–82.
222. Annoni J. M., Devuy G., Carota A. et al. Changes in artistic style after minor posterior stroke // J Neurol. Neurosurg. Psychiatry. – 2005. – V. 76. – № 6. – P. 797–803.
223. Arsovska A., Popovski A. Clinical features of vascular dementia // Neurodegenerative Dis. – 2007. – V. 4 (Suppl 1). – P. 286.
224. Ballard C., Neill D., O’Brien J. et al. Anxiety, depression and psychosis in vascular dementia // J. Affect. Disord. – 2000. – V. 59. – № 1. – P. 97–106.
225. Banwell B. L. Pediatric multiple sclerosis // Current Neurol. Neurosci. Rep. – 2004. – V. 4. – № 1. – P. 245–252.
226. Barczak A., Czyewski K., Luczywek E. et al. Is memory impairment dependent on executive dysfunctions in PD? // Neurodegenerative Dis. – 2007. – V. 4 (Suppl 1). – P. 197–198.
227. Barkley R. A. The executive functions and self regulation // Neuropsychol. Rev. – 2001. – V. 11. – № 1. – P. 1–29.
228. Barone P., Antonini A., Colosimo C. Non-motor symptoms in parkinsonism // Neurodegenerative Dis. – 2007. – V. 4 (Suppl 1). – P. 186–187.
229. Bartsch A. J., Homola G., Biller A. et al. Manifestations of early brain recovery associated with abstinence from alcoholism // Brain. – 2007. – V. 130. – Part 1. – P. 36–47.
230. Belmaker R. H., Agam G. Mayor depressive disorder // N. Engl. J. Med. – 2008. – V. 358. – № 1. – P. 55–68.
231. Benerjee T. D., Middleton F., Faraone S. V. Environmental Risk factirs for attention-deficit hyperactivity disorder // Acta paediatrica. – 2007. – V. 96. – № 9. – P. 1269–1270.
232. Berger J. R., Simpson D. M. Neurologic complications of AIDS. In: Scheld WM et al., eds. Infections of the central nervous system. – Philadelphia: Lippincott-Raven Publishers; 1997. – P. 255–271.
233. Berger-Sweeney J., Hoffmann C. F. Behavioral consequences of abnormal cortical development // Behav. Brain Res. – 1997. – V. 86. – № 2. – P. 121–142.
234. Bhardwaj R. D., Curtis M. A., Spalding K. L. et al. Neocortical neurogenesis in humans is restricted to development // Proc. Nat. Acad. Sci.USA. – 2006. – V. 103. – № 34. – P. 12564–12568.
235. Biju V. M., Raha S. K., Ebenezer L., Wilson S. Prevalence of neuropsychiatric manifestations and sleep disturbances in Parkinsons disease // Neurodegenerative Dis. – 2007. – V. 4 (Suppl 1). – P. 30–31.
236. Bohbot V. D., Bures R. J., Nadel L., Ruricka E. Spatial and nonspatial memory involvement in myasthenia gravis // J. Neurol. – 1997. – V. 244. – № 8. – P. 529–532.
237. Bonino S., Cattelino E., Ciairano S. Adolescents and risk behavior, functions and protective factors. – Aosta: Springer-Verlag, 2005. – 371 p.
238. Borovecki F., Lovrecic L., Zhou J. et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington’s disease // Proc. Nat. Acad. Sci. USA. – 2005. – V. 102. – № 31. – P. 11023– 11028.
239. Bosboom J. L., Stoffers D., Wolters E. S. Cognitive dysfunction and dementia in Parkinsons disease // J. Neural. Transm. – 2004. – V. 111. – № 11. – P. 1303–1315.
240. Brown R. C., Lockwood A. H., Sonawane B. R. Neurodegenerative Diseases: An Overview of Environmental Risk Factors // Environ Health Perspect. – 2005. – V. 113. – № 9. – P. 1250–1256.
